Banzel
NDC 62856-583, rufinamide, tablet, film coated, from Eisai Inc..
- Product NDC
- 62856-583
- Status
- Listed
- Labeler
- Eisai Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021911
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62856-583 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RUFINAMIDE400 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62856-583-14 | 62856058314 | 14 TABLET, FILM COATED in 1 BOTTLE (62856-583-14) |
| 62856-583-52 | 62856058352 | 120 TABLET, FILM COATED in 1 BOTTLE (62856-583-52) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0a3fa925-1abd-458a-bd57-4ae780a1ef2dNADAC price for package 62856058352
GET /v1/drugs/nadac/62856058352
Use it
Look up 62856-583 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62856-583 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62856-583. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.